177 related articles for article (PubMed ID: 17320833)
1. Cholinesterase inhibitors affect brain potentials in amnestic mild cognitive impairment.
Irimajiri R; Michalewski HJ; Golob EJ; Starr A
Brain Res; 2007 May; 1145():108-16. PubMed ID: 17320833
[TBL] [Abstract][Full Text] [Related]
2. Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia.
Golob EJ; Irimajiri R; Starr A
Brain; 2007 Mar; 130(Pt 3):740-52. PubMed ID: 17293359
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
[TBL] [Abstract][Full Text] [Related]
4. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment.
Golob EJ; Johnson JK; Starr A
Clin Neurophysiol; 2002 Jan; 113(1):151-61. PubMed ID: 11801437
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis.
Matsunaga S; Fujishiro H; Takechi H
J Alzheimers Dis; 2019 Aug; 71(2):513-523. PubMed ID: 31424411
[TBL] [Abstract][Full Text] [Related]
6. The visual cognitive network, but not the visual sensory network, is affected in amnestic mild cognitive impairment: a study of brain oscillatory responses.
Yener GG; Emek-Savaş DD; Güntekin B; Başar E
Brain Res; 2014 Oct; 1585():141-9. PubMed ID: 25152459
[TBL] [Abstract][Full Text] [Related]
7. Sensory cortical interactions in aging, mild cognitive impairment, and Alzheimer's disease.
Golob EJ; Miranda GG; Johnson JK; Starr A
Neurobiol Aging; 2001; 22(5):755-63. PubMed ID: 11705635
[TBL] [Abstract][Full Text] [Related]
8. Somatosensory responses in normal aging, mild cognitive impairment, and Alzheimer's disease.
Stephen JM; Montaño R; Donahue CH; Adair JC; Knoefel J; Qualls C; Hart B; Ranken D; Aine CJ
J Neural Transm (Vienna); 2010 Feb; 117(2):217-25. PubMed ID: 20013008
[TBL] [Abstract][Full Text] [Related]
9. Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.
Raschetti R; Albanese E; Vanacore N; Maggini M
PLoS Med; 2007 Nov; 4(11):e338. PubMed ID: 18044984
[TBL] [Abstract][Full Text] [Related]
10. Differences between mild cognitive impairment subtypes as indicated by event-related potential correlates of cognitive and motor processes in a Simon task.
Cespón J; Galdo-Álvarez S; Pereiro AX; Díaz F
J Alzheimers Dis; 2015; 43(2):631-47. PubMed ID: 25125461
[TBL] [Abstract][Full Text] [Related]
11. Nonepisodic memory deficits in amnestic MCI.
Economou A; Papageorgiou SG; Karageorgiou C; Vassilopoulos D
Cogn Behav Neurol; 2007 Jun; 20(2):99-106. PubMed ID: 17558253
[TBL] [Abstract][Full Text] [Related]
12. Auditory brain-stem, middle- and long-latency evoked potentials in mild cognitive impairment.
Irimajiri R; Golob EJ; Starr A
Clin Neurophysiol; 2005 Aug; 116(8):1918-29. PubMed ID: 15998601
[TBL] [Abstract][Full Text] [Related]
13. [Alzheimer drugs for mild cognitive impairment].
Fellgiebel A
Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
[TBL] [Abstract][Full Text] [Related]
14. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
Caselli RJ; Chen K; Lee W; Alexander GE; Reiman EM
Arch Neurol; 2008 Sep; 65(9):1231-6. PubMed ID: 18779428
[TBL] [Abstract][Full Text] [Related]
15. Short latency afferent inhibition is not impaired in mild cognitive impairment.
Sakuma K; Murakami T; Nakashima K
Clin Neurophysiol; 2007 Jul; 118(7):1460-3. PubMed ID: 17462943
[TBL] [Abstract][Full Text] [Related]
16. Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease.
Cancelli I; Cadore IP; Merlino G; Valentinis L; Moratti U; Bergonzi P; Gigli GL; Valente M
J Clin Neurophysiol; 2006 Oct; 23(5):421-5. PubMed ID: 17016152
[TBL] [Abstract][Full Text] [Related]
17. Effects of visual and auditory stimuli on median nerve somatosensory evoked potentials in man.
Okajima Y; Chino N; Takahashi M; Kimura A
Electromyogr Clin Neurophysiol; 1995; 35(4):251-6. PubMed ID: 7555931
[TBL] [Abstract][Full Text] [Related]
18. Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?
Visser PJ; Scheltens P; Verhey FR
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1348-54. PubMed ID: 16170074
[TBL] [Abstract][Full Text] [Related]
19. Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials.
Restuccia D; Della Marca G; Valeriani M; Rubino M; Paciello N; Vollono C; Capuano A; Tonali P
Clin Neurophysiol; 2003 Aug; 114(8):1538-48. PubMed ID: 12888038
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors and beyond.
Pepeu G; Giovannini MG
Curr Alzheimer Res; 2009 Apr; 6(2):86-96. PubMed ID: 19355843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
